Mohr, Peter ; Scherrer, Emilie ; Assaf, Chalid ; Bender, Marc 
; Berking, Carola ; Chandwani, Sheenu ; Eigentler, Thomas ; Grimmelmann, Imke ; Gutzmer, Ralf ; Haferkamp, Sebastian ; Hassel, Jessica ; Hauschild, Axel ; Herbst, Rudolf ; Jiang, Ruixuan ; Kähler, Katharina ; Krepler, Clemens ; Kreuter, Alexander ; Leiter, Ulrike ; Loquai, Carmen ; Meier, Friedegund ; Pföhler, Claudia ; Rudolph, Anja ; Schadendorf, Dirk ; Schiavone, Maximo ; Schley, Gaston ; Terheyden, Patrick ; Ugurel, Selma ; Ulrich, Jens ; Utikal, Jochen ; Weishaupt, Carsten ; Welzel, Julia ; Weichenthal, Michael
; Berking, Carola ; Chandwani, Sheenu ; Eigentler, Thomas ; Grimmelmann, Imke ; Gutzmer, Ralf ; Haferkamp, Sebastian ; Hassel, Jessica ; Hauschild, Axel ; Herbst, Rudolf ; Jiang, Ruixuan ; Kähler, Katharina ; Krepler, Clemens ; Kreuter, Alexander ; Leiter, Ulrike ; Loquai, Carmen ; Meier, Friedegund ; Pföhler, Claudia ; Rudolph, Anja ; Schadendorf, Dirk ; Schiavone, Maximo ; Schley, Gaston ; Terheyden, Patrick ; Ugurel, Selma ; Ulrich, Jens ; Utikal, Jochen ; Weishaupt, Carsten ; Welzel, Julia ; Weichenthal, Michael Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
Mohr, Peter, Scherrer, Emilie, Assaf, Chalid, Bender, Marc, Berking, Carola, Chandwani, Sheenu, Eigentler, Thomas , Grimmelmann, Imke, Gutzmer, Ralf , Haferkamp, Sebastian, Hassel, Jessica , Hauschild, Axel , Herbst, Rudolf , Jiang, Ruixuan , Kähler, Katharina, Krepler, Clemens, Kreuter, Alexander , Leiter, Ulrike, Loquai, Carmen, Meier, Friedegund , Pföhler, Claudia, Rudolph, Anja, Schadendorf, Dirk, Schiavone, Maximo, Schley, Gaston, Terheyden, Patrick, Ugurel, Selma , Ulrich, Jens, Utikal, Jochen , Weishaupt, Carsten , Welzel, Julia and Weichenthal, Michael
(2022)
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany.
Cancers 14 (7), p. 1804.
Date of publication of this fulltext: 29 Feb 2024 13:02
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cancers | ||||
| Publisher: | MDPI | ||||
|---|---|---|---|---|---|
| Place of Publication: | BASEL | ||||
| Volume: | 14 | ||||
| Number of Issue or Book Chapter: | 7 | ||||
| Page Range: | p. 1804 | ||||
| Date | 2022 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie | ||||
| Identification Number |
| ||||
| Keywords | INVESTIGATOR-CHOICE CHEMOTHERAPY; IPILIMUMAB; TRIALS; IV; advanced melanoma; surrogate endpoint; real-world evidence; overall survival (OS); time to next treatment (rwTtNT); pembrolizumab | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 57769 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric